Rabbit Recombinant Monoclonal UQCRB antibody. Suitable for WB, ICC/IF, IHC-P and reacts with Mouse, Human, Rat samples. Cited in 11 publications.
View Alternative Names
UQBP, UQCRB, Cytochrome b-c1 complex subunit 7, Complex III subunit 7, Complex III subunit VII, QP-C, Ubiquinol-cytochrome c reductase complex 14 kDa protein
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-UQCRB antibody [EPR15591] (AB190360)
Immunohistochemical analysis of formalin-fixed paraffin-embedded Human adenocarcinoma of the colon labeling UQCRB with ab190360 at 1/100 and HRP Polymer for Rabbit IgG. Counterstained with hematoxylin. Negative control also shown.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-UQCRB antibody [EPR15591] (AB190360)
Immunocytochemical analysis of HeLa cells fixed in 4% paraformaldehyde labeling UQCRB with ab190360 at 1/250 dilution and Goat anti rabbit IgG (Alexa Fluor® 555) at 1/200 dilution. Counterstained with DAPI. Negative controls also shown.
- WB
Supplier Data
Western blot - Anti-UQCRB antibody [EPR15591] (AB190360)
All lanes:
Western blot - Anti-UQCRB antibody [EPR15591] (ab190360) at 1/5000 dilution
All lanes:
293 cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 14 kDa
Observed band size: 14 kDa
false
- WB
Supplier Data
Western blot - Anti-UQCRB antibody [EPR15591] (AB190360)
All lanes:
Western blot - Anti-UQCRB antibody [EPR15591] (ab190360) at 1/20000 dilution
Lane 1:
HeLa cell lysate at 20 µg
Lane 2:
Human fetal heart tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 14 kDa
Observed band size: 14 kDa
false
- WB
Supplier Data
Western blot - Anti-UQCRB antibody [EPR15591] (AB190360)
All lanes:
Western blot - Anti-UQCRB antibody [EPR15591] (ab190360) at 1/1000 dilution
Lane 1:
Mouse heart tissue lysate at 10 µg
Lane 2:
Rat brain tissue lysate at 10 µg
Lane 3:
NIH/3T3 cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 14 kDa
false
Related conjugates and formulations (1)
-
Anti-UQCRB antibody [EPR15591] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The ubiquinol-cytochrome c reductase binding protein participates in facilitating efficient electron transfer within complex III. As a constituent of the cytochrome bc1 complex UQCRB contributes to the formation of a proton gradient across the mitochondrial membrane which is necessary for the production of ATP. This process is part of oxidative phosphorylation the principal pathway for energy generation in eukaryotic cells. UQCRB interacts closely with other components of the complex III such as cytochrome b and cytochrome c1 ensuring proper electron flow and energy transduction.
Pathways
UQCRB has a pronounced role in the oxidative phosphorylation pathway. This pathway is fundamental in the synthesis of ATP the energy currency in cells through the chemiosmotic coupling of electron transport and phosphorylation. UQCRB serves as a bridging protein for the coherent transfer of electrons from NADH:ubiquinone oxidoreductase (complex I) and succinate dehydrogenase (complex II) towards the cytochrome c oxidase (complex IV). It is intricately linked to other mitochondrial proteins like cytochrome c and ATP synthase that play roles in energy conversion and utilization.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Cell 186:5308-5327.e25 PubMed37922900
2023
Applications
Unspecified application
Species
Unspecified reactive species
Protein & cell 14:202-216 PubMed36929036
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 14: PubMed35454800
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 236:2920-2933 PubMed32930405
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 11:3067 PubMed32546794
2020
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 39:e102817 PubMed31912925
2020
Applications
Unspecified application
Species
Unspecified reactive species
PLoS biology 17:e2006571 PubMed30653498
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 25:1786-1799.e4 PubMed30428348
2018
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of experimental medicine 215:2379-2395 PubMed30061358
2018
Applications
Unspecified application
Species
Unspecified reactive species
Molecular & cellular proteomics : MCP 17:175-189 PubMed29133510
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com